Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:30-35
Published online before print December 15, 2003, doi: 10.1161/01.CIR.0000109482.92774.3A
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/1/30    most recent
01.CIR.0000109482.92774.3Av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brugada, R.
Right arrow Articles by Antzelevitch, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brugada, R.
Right arrow Articles by Antzelevitch, C.
Related Collections
Right arrow Clinical genetics
Right arrow Arrythmias-basic studies
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2004;109:30-35.)
© 2004 American Heart Association, Inc.


Clinical Investigation and Reports

Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG

Ramon Brugada, MD*; Kui Hong, MD, PhD*; Robert Dumaine, PhD; Jonathan Cordeiro, PhD; Fiorenzo Gaita, MD; Martin Borggrefe, MD; Teresa M. Menendez, MD; Josep Brugada, MD, PhD; Guido D. Pollevick, PhD; Christian Wolpert, MD; Elena Burashnikov, MS; Kiyotaka Matsuo, MD, PhD; Yue Sheng Wu, MD; Alejandra Guerchicoff, PhD; Francesca Bianchi, MD; Carla Giustetto, MD; Rainer Schimpf, MD; Pedro Brugada, MD, PhD; Charles Antzelevitch, PhD

From the Molecular Genetics (R.B., K.H., G.D.P., E.B., K.M., A.G.), Molecular Biology (R.D., Y.S.W.), and Experimental Cardiology (J.C., C.A.) Programs, Masonic Medical Research Laboratory, Utica, NY; Division of Cardiology (F.G., F.B., C.G.), Ospedale Mauriziano Umberto I, Torino, Italy; First Department of Medicine (M.B., C.W., R.S.), University Hospital Mannheim, University of Heidelberg, Mannheim, Germany; North Texas Heart Center (T.M.M.), Dallas, Tex; Arrhythmia Section (J.B.), Cardiovascular Institute, Hospital Clínic, Barcelona, Spain; and Cardiovascular Research and Teaching Institute of Aalst (P.B.), Belgium.

Correspondence to Ramon Brugada, MD, Director of Molecular Genetics Program, Masonic Medical Research Laboratory, 2150 Bleecker St, Utica, NY 13501. E-mail brugada{at}mmrl.edu

Received October 21, 2003; revision received November 4, 2003; accepted November 14, 2003.

Background— Sudden cardiac death takes the lives of more than 300 000 Americans annually. Malignant ventricular arrhythmias occurring in individuals with structurally normal hearts account for a subgroup of these sudden deaths. The present study describes the genetic basis for a new clinical entity characterized by sudden death and short-QT intervals in the ECG.

Methods and Results— Three families with hereditary short-QT syndrome and a high incidence of ventricular arrhythmias and sudden cardiac death were studied. In 2 of them, we identified 2 different missense mutations resulting in the same amino acid change (N588K) in the S5-P loop region of the cardiac IKr channel HERG (KCNH2). The mutations dramatically increase IKr, leading to heterogeneous abbreviation of action potential duration and refractoriness, and reduce the affinity of the channels to IKr blockers.

Conclusions— We demonstrate a novel genetic and biophysical mechanism responsible for sudden death in infants, children, and young adults caused by mutations in KCNH2. The occurrence of sudden cardiac death in the first 12 months of life in 2 patients suggests the possibility of a link between KCNH2 gain of function mutations and sudden infant death syndrome. KCNH2 is the binding target for a wide spectrum of cardiac and noncardiac pharmacological compounds. Our findings may provide better understanding of drug interaction with KCNH2 and have implications for diagnosis and therapy of this and other arrhythmogenic diseases.


Key Words: genetics • death, sudden • arrhythmia • ion channels




This article has been cited by other articles:


Home page
Circ Arrhythm ElectrophysiolHome page
J. Cheng, D. W. Van Norstrand, A. Medeiros-Domingo, C. Valdivia, B.-h. Tan, B. Ye, S. Kroboth, M. Vatta, D. J. Tester, C. T. January, et al.
{alpha}1-Syntrophin Mutations Identified in Sudden Infant Death Syndrome Cause an Increase in Late Cardiac Sodium Current
Circ Arrhythm Electrophysiol, December 1, 2009; 2(6): 667 - 676.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Perry, F. B. Sachse, J. Abbruzzese, and M. C. Sanguinetti
PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K+ conductance
PNAS, November 24, 2009; 106(47): 20075 - 20080.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
O. Campuzano and R. Brugada
Genetics of familial atrial fibrillation
Europace, October 1, 2009; 11(10): 1267 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. K. Rudd, J. Keene, B. Bunke, E. B. Kaminsky, M. P. Adam, J. G. Mulle, D. H. Ledbetter, and C. L. Martin
Segmental duplications mediate novel, clinically relevant chromosome rearrangements
Hum. Mol. Genet., August 15, 2009; 18(16): 2957 - 2962.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
D. P. McEwen and J. R. Martens
Antifibrillatory Agents and Potassium Channels in the Atria: Pore Block versus Channel Trafficking
Mol. Interv., April 1, 2009; 9(2): 79 - 86.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Li, V. Timofeyev, D. Tuteja, D. Xu, L. Lu, Q. Zhang, Z. Zhang, A. Singapuri, T. R. Albert, A. V. Rajagopal, et al.
Ablation of a Ca2+-activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation
J. Physiol., March 1, 2009; 587(5): 1087 - 1100.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
F. G. Cosío, J.#x. Palacios, A.#x.;n Pastor, and A. Núñez
CHAPTER 2 The Electrocardiogram
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
S. G. Priori, C. Napolitano, S. E. Humphries, and J. Skipworth
CHAPTER 9 Genetics of Cardiovascular Diseases
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Nattel
Delayed-rectifier potassium currents and the control of cardiac repolarization: Noble and Tsien 40 years after
J. Physiol., December 15, 2008; 586(24): 5849 - 5852.
[Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
D. W. Wang, L. Crotti, W. Shimizu, M. Pedrazzini, F. Cantu, P. De Filippo, K. Kishiki, A. Miyazaki, T. Ikeda, P. J. Schwartz, et al.
Malignant Perinatal Variant of Long-QT Syndrome Caused by a Profoundly Dysfunctional Cardiac Sodium Channel
Circ Arrhythm Electrophysiol, December 1, 2008; 1(5): 370 - 378.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. J. Perrin, P. W. Kuchel, T. J. Campbell, and J. I. Vandenberg
Drug Binding to the Inactivated State Is Necessary but Not Sufficient for High-Affinity Binding to Human Ether-a-go-go-Related Gene Channels
Mol. Pharmacol., November 1, 2008; 74(5): 1443 - 1452.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. Noseworthy and C. Newton-Cheh
Genetic Determinants of Sudden Cardiac Death
Circulation, October 28, 2008; 118(18): 1854 - 1863.
[Full Text] [PDF]


Home page
Circ. Res.Home page
H. M. Barajas-Martinez, D. Hu, J. M. Cordeiro, Y. Wu, R. J. Kovacs, H. Meltser, H. Kui, B. Elena, R. Brugada, C. Antzelevitch, et al.
Lidocaine-Induced Brugada Syndrome Phenotype Linked to a Novel Double Mutation in the Cardiac Sodium Channel
Circ. Res., August 15, 2008; 103(4): 396 - 404.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. R. Behr, C. Dalageorgou, M. Christiansen, P. Syrris, S. Hughes, M. T. Tome Esteban, E. Rowland, S. Jeffery, and W. J. McKenna
Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families
Eur. Heart J., July 1, 2008; 29(13): 1670 - 1680.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X. Xu, M. Recanatini, M. Roberti, and G.-N. Tseng
Probing the Binding Sites and Mechanisms of Action of Two Human Ether-a-go-go-Related Gene Channel Activators, 1,3-bis-(2-Hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243)
Mol. Pharmacol., June 1, 2008; 73(6): 1709 - 1721.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. C. Hancox and A. F. James
Refining Insights into High-Affinity Drug Binding to the Human Ether-a-go-go-Related Gene Potassium Channel
Mol. Pharmacol., June 1, 2008; 73(6): 1592 - 1595.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Circulation, May 27, 2008; 117(21): e350 - e408.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Gordon, I. M. Lozinskaya, Z. Lin, S. F. Semus, F. E. Blaney, R. N. Willette, and X. Xu
2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic Acid (PD-307243) Causes Instantaneous Current through Human Ether-a-go-go-Related Gene Potassium Channels
Mol. Pharmacol., March 1, 2008; 73(3): 639 - 651.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al.
Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function
Circulation, November 13, 2007; 116(20): 2325 - 2345.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. A. Stephenson and C. I. Berul
Electrophysiological Interventions for Inherited Arrhythmia Syndromes
Circulation, August 28, 2007; 116(9): 1062 - 1080.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Perry, F. B. Sachse, and M. C. Sanguinetti
Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator
PNAS, August 21, 2007; 104(34): 13827 - 13832.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. N. Viswanathan and R. L. Page
Short QT: When Does It Matter?
Circulation, August 14, 2007; 116(7): 686 - 688.
[Full Text] [PDF]


Home page
CirculationHome page
D. Fatkin, R. Otway, and J. I. Vandenberg
Genes and Atrial Fibrillation: A New Look at an Old Problem
Circulation, August 14, 2007; 116(7): 782 - 792.
[Full Text] [PDF]


Home page
ChestHome page
M. G. Reinig and T. R. Engel
The Shortage of Short QT Intervals
Chest, July 1, 2007; 132(1): 246 - 249.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E R Behr, A Casey, M Sheppard, M Wright, T J Bowker, M J Davies, W J McKenna, and D A Wood
Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death
Heart, May 1, 2007; 93(5): 601 - 605.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Antzelevitch, G. D. Pollevick, J. M. Cordeiro, O. Casis, M. C. Sanguinetti, Y. Aizawa, A. Guerchicoff, R. Pfeiffer, A. Oliva, B. Wollnik, et al.
Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death
Circulation, January 30, 2007; 115(4): 442 - 449.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Schulze-Bahr
Arrhythmia Predisposition: Between Rare Disease Paradigms and Common Ion Channel Gene Variants
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A67 - A78.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Giustetto, F. Di Monte, C. Wolpert, M. Borggrefe, R. Schimpf, P. Sbragia, G. Leone, P. Maury, O. Anttonen, M. Haissaguerre, et al.
Short QT syndrome: clinical findings and diagnostic-therapeutic implications
Eur. Heart J., October 2, 2006; 27(20): 2440 - 2447.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. S. Hansen, T. G. Diness, T. Christ, E. Wettwer, U. Ravens, S.-P. Olesen, and M. Grunnet
Biophysical Characterization of the New Human Ether-A-Go-Go-Related Gene Channel Opener NS3623 [N-(4-Bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea]
Mol. Pharmacol., October 1, 2006; 70(4): 1319 - 1329.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
J. Physiol.Home page
C. E. Clarke, A. P. Hill, J. Zhao, M. Kondo, R. N. Subbiah, T. J. Campbell, and J. I. Vandenberg
Effect of S5P {alpha}-helix charge mutants on inactivation of hERG K+ channels
J. Physiol., June 1, 2006; 573(2): 291 - 304.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Patterson, R. Lazzara, B. Szabo, H. Liu, D. Tang, Y.-H. Li, B. J. Scherlag, and S. S. Po
Sodium-Calcium Exchange Initiated by the Ca2+ Transient: An Arrhythmia Trigger Within Pulmonary Veins
J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1196 - 1206.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. G. Priori and C. Napolitano
Role of Genetic Analyses in Cardiology: Part I: Mendelian Diseases: Cardiac Channelopathies
Circulation, February 28, 2006; 113(8): 1130 - 1135.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M Sugao, A Fujiki, M Sakabe, K Nishida, T Tsuneda, J Iwamoto, K Mizumaki, and H Inoue
New quantitative methods for evaluation of dynamic changes in QT interval on 24 hour Holter ECG recordings: QT interval in idiopathic ventricular fibrillation and long QT syndrome
Heart, February 1, 2006; 92(2): 201 - 207.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
R. Brugada, K. Hong, J. M. Cordeiro, and R. Dumaine
Short QT syndrome
Can. Med. Assoc. J., November 22, 2005; 173(11): 1349 - 1354.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
H. Chapman, C. Ramstrom, L. Korhonen, M. Laine, K. T. Wann, D. Lindholm, M. Pasternack, and K. Tornquist
Downregulation of the HERG (KCNH2) K+ channel by ceramide: evidence for ubiquitin-mediated lysosomal degradation
J. Cell Sci., November 15, 2005; 118(22): 5325 - 5334.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. M. Nerbonne and R. S. Kass
Molecular Physiology of Cardiac Repolarization
Physiol Rev, October 1, 2005; 85(4): 1205 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
S Chakrabarti and A G Stuart
Understanding cardiac arrhythmias
Arch. Dis. Child., October 1, 2005; 90(10): 1086 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. Shimizu
The long QT syndrome: Therapeutic implications of a genetic diagnosis
Cardiovasc Res, August 15, 2005; 67(3): 347 - 356.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Schimpf, C. Wolpert, F. Gaita, C. Giustetto, and M. Borggrefe
Short QT syndrome
Cardiovasc Res, August 15, 2005; 67(3): 357 - 366.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Kaab and E. Schulze-Bahr
Susceptibility genes and modifiers for cardiac arrhythmias
Cardiovasc Res, August 15, 2005; 67(3): 397 - 413.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. D.C. Paulussen, A. Raes, R. J. Jongbloed, R. A.H.J. Gilissen, A. A.M. Wilde, D. J. Snyders, H. J.M. Smeets, and J. Aerssens
HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency
Cardiovasc Res, August 15, 2005; 67(3): 467 - 475.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.M. Cordeiro, R. Brugada, Y.S. Wu, K. Hong, and R. Dumaine
Modulation of IKr inactivation by mutation N588K in KCNH2: A link to arrhythmogenesis in short QT syndrome
Cardiovasc Res, August 15, 2005; 67(3): 498 - 509.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. R. Ehrlich, S. Zicha, P. Coutu, T. E. Hebert, and S. Nattel
Atrial fibrillation-associated minK38G/S polymorphism modulates delayed rectifier current and membrane localization
Cardiovasc Res, August 15, 2005; 67(3): 520 - 528.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. P. Zipes, M. J. Ackerman, N.A. M. Estes III, A. O. Grant, R. J. Myerburg, and G. Van Hare
Task Force 7: Arrhythmias
J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1354 - 1363.
[Full Text] [PDF]


Home page
Circ. Res.Home page
E. Schulze-Bahr
Short QT Syndrome or Andersen Syndrome: Yin and Yang of Kir2.1 Channel Dysfunction
Circ. Res., April 15, 2005; 96(7): 703 - 704.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. G. Priori, S. V. Pandit, I. Rivolta, O. Berenfeld, E. Ronchetti, A. Dhamoon, C. Napolitano, J. Anumonwo, M. R. di Barletta, S. Gudapakkam, et al.
A Novel Form of Short QT Syndrome (SQT3) Is Caused by a Mutation in the KCNJ2 Gene
Circ. Res., April 15, 2005; 96(7): 800 - 807.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
T. T. Beery
The Genetics of Cardiac Arrhythmias
Biol Res Nurs, April 1, 2005; 6(4): 249 - 261.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
M. M. Scheinman and E. Keung
The year in clinical electrophysiology
J. Am. Coll. Cardiol., March 1, 2005; 45(5): 790 - 795.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. A. Fossa, T. Wisialowski, A. Magnano, E. Wolfgang, R. Winslow, W. Gorczyca, K. Crimin, and D. L. Raunig
Dynamic Beat-to-Beat Modeling of the QT-RR Interval Relationship: Analysis of QT Prolongation during Alterations of Autonomic State versus Human Ether a-go-go-Related Gene Inhibition
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Grom, T. S. Faber, M. Brunner, C. Bode, and M. Zehender
Delayed adaptation of ventricular repolarization after sudden changes in heart rate due to conversion of atrial fibrillation. A potential risk factor for proarrhythmia?
Europace, January 1, 2005; 7(2): 113 - 121.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. Antzelevitch
Cardiac repolarization. The long and short of it
Europace, January 1, 2005; 7(s2): S3 - S9.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
D. L. Weiss, G. Seemann, F. B. Sachse, and O. Dössel
Modelling of short QT syndrome in a heterogeneous model of the human ventricular wall
Europace, January 1, 2005; 7(s2): S105 - S117.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Royer, S. Demolombe, A. El Harchi, K. Le Quang, J. Piron, G. Toumaniantz, D. Mazurais, C. Bellocq, G. Lande, C. Terrenoire, et al.
Expression of human ERG K+ channels in the mouse heart exerts anti-arrhythmic activity
Cardiovasc Res, January 1, 2005; 65(1): 128 - 137.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Extramiana and C. Antzelevitch
Amplified Transmural Dispersion of Repolarization as the Basis for Arrhythmogenesis in a Canine Ventricular-Wedge Model of Short-QT Syndrome
Circulation, December 14, 2004; 110(24): 3661 - 3666.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. F. Tomaselli and D. P. Zipes
What Causes Sudden Death in Heart Failure?
Circ. Res., October 15, 2004; 95(8): 754 - 763.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Thiene, D. Corrado, and C. Basso
Cardiomyopathies: is it time for a molecular classification?
Eur. Heart J., October 2, 2004; 25(20): 1772 - 1775.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Gaita, C. Giustetto, F. Bianchi, R. Schimpf, M. Haissaguerre, L. Calo, R. Brugada, C. Antzelevitch, M. Borggrefe, and C. Wolpert
Short QT syndrome: pharmacological treatment
J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1494 - 1499.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. P. Zipes
The year in electrophysiology
J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1306 - 1314.
[Full Text] [PDF]


Home page
Circ. Res.Home page
D. E. Arking, S. S. Chugh, A. Chakravarti, and P. M. Spooner
Genomics in Sudden Cardiac Death
Circ. Res., April 2, 2004; 94(6): 712 - 723.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. O. Cheng, F. Gaita, C. Giustetto, F. Bianchi, R. Riccardi, S. Grossi, E. Richiardi, C. Wolpert, R. Schimpf, and M. Borggrefe
Digitalis Administration: An Underappreciated but Common Cause of Short QT Interval * Response
Circulation, March 9, 2004; 109 (9): e152 - e152.
[Full Text] [PDF]